Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents
Enterocolic lymphocytic phlebitis is phlebitis of unknown etiology in which lymphocytes affect veins without arteries and shows evidence of systemic vasculitis in the intestinal wall and mesentery, mainly in the small intestine and colon. Although patients present with a variety of gastrointestinal...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Pathology |
| Online Access: | http://dx.doi.org/10.1155/2022/5120607 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549577227501568 |
|---|---|
| author | Soh Okano Takashi Yao Osamu Nomura Akihito Nagahara Toshiaki Hagiwara Kiichi Sugimoto Makoto Takahashi Kazuhiro Sakamoto |
| author_facet | Soh Okano Takashi Yao Osamu Nomura Akihito Nagahara Toshiaki Hagiwara Kiichi Sugimoto Makoto Takahashi Kazuhiro Sakamoto |
| author_sort | Soh Okano |
| collection | DOAJ |
| description | Enterocolic lymphocytic phlebitis is phlebitis of unknown etiology in which lymphocytes affect veins without arteries and shows evidence of systemic vasculitis in the intestinal wall and mesentery, mainly in the small intestine and colon. Although patients present with a variety of gastrointestinal symptoms and findings like those of inflammatory bowel disease or ischemic bowel disease, there are no specific findings for enterocolic lymphocytic phlebitis. As a result, a diagnosis tends to be made after surgery. There are few case reports of enterocolic lymphocytic phlebitis, and the impact of chronic courses and immunosuppressive drugs on enterocolic lymphocytic phlebitis is not well known. A 47-year-old man was treated with infliximab and steroids for unexplained ulceration and narrowing of the ileocecal area, which was suspected to be inflammatory bowel disease with atypical findings. Lymphocytic phlebitis was noted in the surgical specimen, and enterocolic lymphocytic phlebitis was diagnosed. No recurrence of enterocolic lymphocytic phlebitis was observed postoperatively. This disease should also be considered among patients with inflammatory bowel disease-like lesions that do not respond to infliximab or steroids. |
| format | Article |
| id | doaj-art-613df2323190401a8b17e1baf0123473 |
| institution | Kabale University |
| issn | 2090-679X |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Pathology |
| spelling | doaj-art-613df2323190401a8b17e1baf01234732025-02-03T06:10:54ZengWileyCase Reports in Pathology2090-679X2022-01-01202210.1155/2022/5120607Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive AgentsSoh Okano0Takashi Yao1Osamu Nomura2Akihito Nagahara3Toshiaki Hagiwara4Kiichi Sugimoto5Makoto Takahashi6Kazuhiro Sakamoto7Department of Human PathologyDepartment of Human PathologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of Coloproctological SurgeryDepartment of Coloproctological SurgeryDepartment of Coloproctological SurgeryDepartment of Coloproctological SurgeryEnterocolic lymphocytic phlebitis is phlebitis of unknown etiology in which lymphocytes affect veins without arteries and shows evidence of systemic vasculitis in the intestinal wall and mesentery, mainly in the small intestine and colon. Although patients present with a variety of gastrointestinal symptoms and findings like those of inflammatory bowel disease or ischemic bowel disease, there are no specific findings for enterocolic lymphocytic phlebitis. As a result, a diagnosis tends to be made after surgery. There are few case reports of enterocolic lymphocytic phlebitis, and the impact of chronic courses and immunosuppressive drugs on enterocolic lymphocytic phlebitis is not well known. A 47-year-old man was treated with infliximab and steroids for unexplained ulceration and narrowing of the ileocecal area, which was suspected to be inflammatory bowel disease with atypical findings. Lymphocytic phlebitis was noted in the surgical specimen, and enterocolic lymphocytic phlebitis was diagnosed. No recurrence of enterocolic lymphocytic phlebitis was observed postoperatively. This disease should also be considered among patients with inflammatory bowel disease-like lesions that do not respond to infliximab or steroids.http://dx.doi.org/10.1155/2022/5120607 |
| spellingShingle | Soh Okano Takashi Yao Osamu Nomura Akihito Nagahara Toshiaki Hagiwara Kiichi Sugimoto Makoto Takahashi Kazuhiro Sakamoto Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents Case Reports in Pathology |
| title | Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents |
| title_full | Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents |
| title_fullStr | Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents |
| title_full_unstemmed | Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents |
| title_short | Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents |
| title_sort | enterocolic lymphocytic phlebitis treated preoperatively with biologics and immunosuppressive agents |
| url | http://dx.doi.org/10.1155/2022/5120607 |
| work_keys_str_mv | AT sohokano enterocoliclymphocyticphlebitistreatedpreoperativelywithbiologicsandimmunosuppressiveagents AT takashiyao enterocoliclymphocyticphlebitistreatedpreoperativelywithbiologicsandimmunosuppressiveagents AT osamunomura enterocoliclymphocyticphlebitistreatedpreoperativelywithbiologicsandimmunosuppressiveagents AT akihitonagahara enterocoliclymphocyticphlebitistreatedpreoperativelywithbiologicsandimmunosuppressiveagents AT toshiakihagiwara enterocoliclymphocyticphlebitistreatedpreoperativelywithbiologicsandimmunosuppressiveagents AT kiichisugimoto enterocoliclymphocyticphlebitistreatedpreoperativelywithbiologicsandimmunosuppressiveagents AT makototakahashi enterocoliclymphocyticphlebitistreatedpreoperativelywithbiologicsandimmunosuppressiveagents AT kazuhirosakamoto enterocoliclymphocyticphlebitistreatedpreoperativelywithbiologicsandimmunosuppressiveagents |